Australia Metabolic Disorder Therapeutics Market Analysis


  • Type: Therapeutics Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4006

  • Format: PPT, PDF

Australian Metabolic Disorder Therapeutics Market: Segmented by Therapy Type (Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, and Drug Therapy), and by Route of Administration (Oral, Parenteral and Others) – Growth, Trends, and Forecast (2019 – 2028)

SKU: 4006 Categories: ,

Report Overview

The Australian Metabolic Disorders Therapeutics market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The metabolic disorder is increasingly common, both in Australia and overseas. The Australian Diabetes, Obesity and Lifestyle study in 2000, found that 19% of Australians aged 25 years and over met the criteria for a diagnosis of metabolic disorder. The follow-up study in 2004–05, found the annual incidence of the metabolic disorder to be 3%. In 2006 Bettering the Evaluation and Care of Health (BEACH) study found that while 43.7% of patients had central obesity, 15.6% had metabolic disorders. Metabolism is the process through which the body generates energy from food. Food comprises biomolecules, including carbohydrates, proteins, and fats. Chemicals in the digestive system are used to break the food into sugars and acids. Metabolic disorders disrupt the normal function of metabolic processes and lead to excess or lack of essential components that are needed to stay healthy. These disorders are either inherited or acquired during the lifetime of an individual.

Market Drivers

Increasing demand for one-time therapies for metabolic disorders and the rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market. Various governments and healthcare associations around the world have estimated that more than half a billion individuals are to be affected by obesity and diabetes by 2040. Also, rising incidences of inherited metabolic diseases due to changing lifestyles are likely to propel the market growth. Other factors that are propelling the market growth are the rapidly aging population, sedentary lifestyles, and increasing cases of smoking and other metabolic pathway restricting practices. The latest data from the National Drug Strategy Household Survey (NDSHS) estimated that 11.6% of adults smoked daily in 2019. The National Health Survey 2014-15 indicates that nearly 30% of Australian adults engaged in low levels of physical activity (less than 150 minutes in the last week) while 14.8% were inactive (no exercise in the last week). Similar proportions of males (15.2%) and females were considered inactive (14.4%).

Major Metabolic Disorders

The major disorders include diabetes, lysosomal disorders, hypercholesterolemia, obesity, and inherited metabolic disorders. These diseases are mostly inherited from the older generation through a faulty gene and some show immediate effects like the lysosomal disorders, while some show up later due to aging.

Diabetes was estimated to be the largest segment due to the wide usage of metabolic disease therapies in anti-diabetic drugs and injections to control blood sugar levels. In diabetes, constant ingestion of metabolic regulators is essential. This factor makes it the largest revenue-generating segment. However, the obesity segment is expected to witness the fastest growth over the forecast period due to increasing lifestyle changes and unhealthy eating habits. In 2017–18, an estimated 2 in 3 (67%) Australians aged 18 and over were overweight or obese.

1. Australian Metabolic Disorders Therapeutics Market Overview………………………..
A. Market Size
2. Market Growth Drivers…………………………………………….……………………….
A. Increase Prevalence of Metabolic Disorders
B. Increasing Cases of Smoking and Sedentary Lifestyles
C. Government Initiatives
3. Major Metabolic Disorders………………….………………………………………….…
A. Lysosomal Storage Diseases
B. Diabetes
C. Obesity
D. Inherited Metabolic Disorders
E. Hypercholesterolemia
4. Metabolic Disorders Therapeutics Market Segmentation…………………………………
A. Therapy
I. Enzyme Replacement Therapy
II. Cellular Transplantation
III. Small Molecule Based Therapy
IV. Substrate Reduction Therapy
V. Gene Therapy
VI. Drug Therapy
B. Route of Administration
I. Oral
II. Parenteral
III. Others
5. Metabolic Disorders Therapeutics Major Products Market Share………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………….………….…………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………….
A. Boehringer Ingelheim Company overview, Product & Services, Strategies & Financials
B. Sanofi Company overview, Product & Services, Strategies & Financials
C. Novo Nordisk Company overview, Product & Services, Strategies & Financials
D. Bio-Rad Laboratories overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development of Metabolic Disorders Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Therapy:

Based on therapy, the market is segmented into enzyme replacement therapy, cellular transplantation, substrate reduction therapy, small molecule-based therapy, gene therapy, and drug therapy. Except for drug therapy, all the other therapies are novel and cutting-edge, which makes them more effective in treating metabolic diseases. However, the downside of these therapies is high costs and a lack of solid scientific backup.

Drug therapy held the highest market share due to its extensive usage as a result of ease of administration and high-reliability rate. This therapy is expected to maintain its growth even during the forecast period owing to its advanced ways of administering medications without disturbing day-to-day patient lives. Moreover, the introduction of smart drug delivery devices and smart dosage control methods are projected to drive the segment further.

By Route of Administration:

Based on the route of administration, the market is segmented into oral, parenteral, and other routes of administration. The oral route of the administration segment was the key revenue-generating segment due to wide usage in diabetes and hypercholesterolemia treatments. The rise in demand for safe and smart drug delivery has driven the growth in this segment because of the ease of use, reliability, and proven results offered by the oral route of administration.

Major Players

The Australian metabolic disorder market is moderately competitive. Some of the major players of this market are Novo Nordisk A/S; Sanofi S.A.; Boehringer Ingelheim GmbH; Eli Lilly and Company; Merck KgaA; Amgen, Inc.; AstraZeneca PLC; Actelion Pharmaceuticals Ltd.; Shire PLC; AbbVie, Inc.; Biocon Ltd.; BioMarin Pharmaceutical, Inc.; Bristol-Myers Squibb Company; Cipla, Inc.; and CymaBay Therapeutics.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements